Excess risk of death increases with time from first dialysis for patients on the waiting list: Implications for renal allograft allocation policy

Nephron - Clinical Practice

Volumn 124, Issue 1-2, 2013, Pages 99-105

  Bouaoun, Liacine ^a,b,c   Villar, Emmanuel ^a,d   Ecochard, René ^a,b,c   Couchoud, Cécile ^e  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^d CENTRE HOSPITALIER SAINT JOSEPH SAINT LUC   (France)

^e AGENCE DE LA BIOMÉDECINE   (France)

Author keywords

Excess risk of death; Kidney; Organ allocation; Transplantation; Waiting list

Indexed keywords

AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC RESPIRATORY FAILURE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GENDER; HEALTH CARE POLICY; HEART FAILURE; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REGISTRATION; RISK ASSESSMENT; TIME; TRANSIENT ISCHEMIC ATTACK;

AGED; FEMALE; FRANCE; HEALTH CARE RATIONING; HEALTH POLICY; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PATIENT SELECTION; REGISTRIES; RENAL DIALYSIS; RESOURCE ALLOCATION; RISK FACTORS; SURVIVAL RATE; WAITING LISTS;

EID: 84886739671     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000355549     Document Type: Article

References (24)

1. Renal Epidemiology and Information Network: 2010 Annual Report. Nephrol Ther 2012; 8(supp 1):S1-S168.
2. US Renal Data System, USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010.
3. McDonald SP, Russ GR, Kerr PG, Collins JF, Australia and New Zealand Dialysis and Transplant Registry: ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry. Am J Kidney Dis 2002; 40: 1122-1131.
4. Kramer A, Stel V, Zoccali C, et al. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol Dial Transplant 2009; 24: 3557-3566.
5. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
6. McDonald SP, Russ GR. Survival of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991-2001. Nephrol Dial Transplant 2002; 17: 2212-2219.
7. Rabbat CG, Thorpe KE, Russell JD, Churchill DN. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. J Am Soc Nephrol 2000; 11: 917-922.
8. Medin C, Elinder CG, Hylander B, Blom B, Wilczek H. Survival of patients who have been on a waiting list for renal transplantation. Nephrol Dial Transplant 2000; 15: 701-704.
9. Johnson DW, Herzig K, Purdie D, et al. A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients. Transplantation 2000; 69: 794-799.
10. Villar E, Rabilloud M, Berthoux P, Vialtel P, Labeeuw M, Pouteil-Noble C. A multicentre study of registration on renal transplantation waiting list of the elderly and patients with type 2 diabetes. Nephrol Dial Transplant 2004; 19: 207-214.
11. Bayat S, Frimat L, Thilly N, Loos C, Briançon S, Kessler M. Medical and non-medical determinants of access to renal transplant waiting list in a French community-based network of care. Nephrol Dial Transplant 2006; 21: 2900-2907.
12. Oniscu GC, Schalkwijk AA, Johnson RJ, Brown H, Forsythe JL. Equity of access to renal transplant waiting list and renal transplantation in Scotland: cohort study. BMJ 2003; 327: 1261.
13. Descamps C, Labeeuw M, Trolliet P, et al. Confounding factors for early death in endstage renal disease patients: role of emergency dialysis start. Hemodial Int 2011; 15: 23-29.
14. Karamá A, Labeeuw M, Trolliet P, et al. The impact of type 2 diabetes on mortality in endstage renal disease patients differs between genders. Nephron Clin Pract 2009; 112:c268-c275.
15. Snyder JJ, Kasiske BL, Maclean R. Peripheral arterial disease and renal transplantation. J Am Soc Nephrol 2006; 17: 2056-2068.
16. Villar E, Remontet L, Labeeuw M, Ecochard R. Effect of age, sex and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol 2007; 18: 2125-2134.
17. Couchoud C, Stengel B, Landais P, et al. The Renal Epidemiology and Information Network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant 2006; 21: 411-418.
18. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol. II: The Design and Analysis of Cohort Studies. Lyon, International Agency for Research on Cancer Press, 1987, pp 1-406.
19. Hakulinen T, Tenkanen L. Regression analysis of relative survival rates. Appl Stat 1987; 36: 309-317.
20. McCullagh P, Nelder JA. Generalized Linear Models, ed 2. Boca Raton, Chapman & Hall/ CRC, 1989, pp 40-43.
21. Couchoud C, Lassalle M, Stengel B, Jacquelinet C. Rapport annuel 2009. Ráseau Epidámiologie et Information en Náphrologie. http://www. agence-biomedecine.fr/uploads/document/ Rapport-REIN-2009-Web%20sept2011.pdf (accessed November 25, 2011).
22. Jacquelinet C, Audry B, Golbreich C, et al. Changing Kidney Allocation Policy in France: The Value of Simulation. AMIA Annu Symp Proc, 2006, pp 374-378.
23. Schold JD, Meier-Kriesche HU. Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis?. Clin J Am Soc Nephrol 2006; 1: 532-538.
24. Courtney AE, Maxwell AP. The challenge of doing what is right in renal transplantation: balancing equity and utility. Nephron Clin Pract 2009; 111:c62-c68.